Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA Locations section is now shown with Massachusetts listed as a site. The page revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link as well as the older Massachusetts Locations entry were removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted,' indicating that results for the trial are being prepared for release.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no visible changes to the study details or layout.SummaryDifference0.0%

- Check47 days agoChange Detected- The top government funding/status banner was removed. The study details and eligibility information on the page remain unchanged.SummaryDifference0.3%

- Check62 days agoChange DetectedMinor UI/formatting updates observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.